Andrea K Knittel1, Bonnie E Shook-Sa2, Jacqueline E Rudolph3, Andrew Edmonds3, Catalina Ramirez4, Mardge H Cohen5, Adebola Adedimeji6, Tonya N Taylor7, Katherine G Michel8, Joel Milam9, Jennifer Cohen10, Jessica D Donohue11, Antonina Foster12, Margaret Fischl13, Deborah Konkle-Parker14, Adaora A Adimora4. 1. Department of Obstetrics and Gynecology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA. 2. Department of Biostatistics and University of North Carolina at Chapel Hill Gillings School of Global Public Health, Chapel Hill, North Carolina, USA. 3. Department of Epidemiology, University of North Carolina at Chapel Hill Gillings School of Global Public Health, Chapel Hill, North Carolina, USA. 4. Institute for Global Health & Infectious Diseases, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA. 5. Stroger Hospital, Chicago, Illinois, USA. 6. Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Brooklyn, New York, USA. 7. Division of Infectious Disease, SUNY Downstate Medical Center, College of Medicine, Brooklyn, New York, USA. 8. Department of Infectious Diseases, Georgetown University, Washington, District of Columbia, USA. 9. Department of Preventive Medicine, University of Southern California, Los Angeles, California, USA. 10. Department of Medicine, University of California San Francisco, San Francisco, California, USA. 11. WIHS Data Management and Analysis Center, Johns Hopkins University, Baltimore, Maryland, USA. 12. Division of Infectious Disease, Department of Medicine, Emory University, Atlanta, Georgia, USA. 13. Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA. 14. Division of Infectious Diseases, Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA.
Abstract
Background: To estimate the incidence, prevalence, frequency, and duration of incarceration and to identify risk factors for incarceration among women at risk for human immunodeficiency virus (HIV) in the United States. Methods: During semiannual study visits in a multicenter cohort study, 970 HIV sero-negative participants at risk for HIV were asked about their own incarceration (10/2007-09/2017) and incarceration of sexual partners (10/2013-09/2017). We used descriptive statistics and multivariable log-binomial regression to identify baseline predictors of incident incarceration. Results: Median follow-up time across the 970 participants was 5.5 years (IQR 3.5-9.5). Nearly half (n = 453, 46.7%) of participants were incarcerated during or before the study, and the incarceration rate was 5.5 per 100 person-years. In multivariable models, incident incarceration was associated with prior incarceration (RR 5.20, 95% CI: 3.23-8.41) and noninjection drug use (RR 1.57, 95% CI: 1.10-2.25). Conclusions: Incarceration is common for women at risk for HIV. Prevention interventions that address the complex interplay of drug use, sex exchange, and housing instability for women who have experienced incarceration have the potential to reach an important group of U.S. women at risk of HIV infection.
Background: To estimate the incidence, prevalence, frequency, and duration of incarceration and to identify risk factors for incarceration among women at risk for human immunodeficiency virus (HIV) in the United States. Methods: During semiannual study visits in a multicenter cohort study, 970 HIV sero-negative participants at risk for HIV were asked about their own incarceration (10/2007-09/2017) and incarceration of sexual partners (10/2013-09/2017). We used descriptive statistics and multivariable log-binomial regression to identify baseline predictors of incident incarceration. Results: Median follow-up time across the 970 participants was 5.5 years (IQR 3.5-9.5). Nearly half (n = 453, 46.7%) of participants were incarcerated during or before the study, and the incarceration rate was 5.5 per 100 person-years. In multivariable models, incident incarceration was associated with prior incarceration (RR 5.20, 95% CI: 3.23-8.41) and noninjection drug use (RR 1.57, 95% CI: 1.10-2.25). Conclusions: Incarceration is common for women at risk for HIV. Prevention interventions that address the complex interplay of drug use, sex exchange, and housing instability for women who have experienced incarceration have the potential to reach an important group of U.S. women at risk of HIV infection.
Authors: Catherine I Fogel; Deborah J Gelaude; Monique Carry; Jeffrey H Herbst; Sharon Parker; Anna Scheyette; A Neevel Journal: Women Health Date: 2014
Authors: Kim M Blankenship; Ana Maria Del Rio Gonzalez; Danya E Keene; Allison K Groves; Alana P Rosenberg Journal: Soc Sci Med Date: 2018-09-01 Impact factor: 4.634
Authors: Adaora A Adimora; Catalina Ramirez; Lorie Benning; Ruth M Greenblatt; Mirjam-Colette Kempf; Phyllis C Tien; Seble G Kassaye; Kathryn Anastos; Mardge Cohen; Howard Minkoff; Gina Wingood; Igho Ofotokun; Margaret A Fischl; Stephen Gange Journal: Int J Epidemiol Date: 2018-04-01 Impact factor: 7.196
Authors: Lakshmi Goparaju; Nathan C Praschan; Lari Warren-Jeanpiere; Laure S Experton; Mary A Young; Seble Kassaye Journal: J AIDS Clin Res Date: 2017-09-25